Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD4 (clone gOKT4IA-4I). We employs the Lentivirus (SV40-BFP-IL-4-KpnI) vector components and the SynExpress system of the Exons Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD4
Clone
gOKT4IA-4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
SV40
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.95
Cell Culture
Microcarrier Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.